Philanthropic Billionaire Going Tech with Health Research and Treatment

Home / Philanthropic Billionaire Going Tech with Health Research and Treatment

One of the world’s billionaires, a committed father and husband, a selfless giver and an experienced businessman are some of the few phrases that can be used to describe Eric Lefkofsky. This self-made billionaire ventured into the business world while still a student at the University of Michigan, where his first venture was selling carpets. The now father of 3 has had vast experience in the business world. He was a CEO and the co-founder of Groupon, Chicago venture capital firm Lightbank, which is one of Chicago’s most powerful and influential tech companies, and founder of Uptake.

Currently, the tireless man is working with Tempus as the founder and CEO of this health-tech company that is working towards providing best cancer treatment to patients. The company uses modern technology, medical genome studies as well employing machine-learning techniques to understand the disease entirely before treating the patients. Tempus, which is currently working with patients who have pancreatic cancer, breast cancer, and liver cancer, promises to expand and cover other types of cancer. It has employed some of the most experienced and qualified people in the fields of medicine, engineering as well as in leadership and business management.

Besides many business ventures, Eric Lefkofsky is a generous man who has time and again given big resources to cancer research centers like the Robert H. Lurie Comprehensive Cancer Center of Northwestern and the University of Michigan cancer research. His love for supporting healthcare programs comes out clearly, as he is also a trustee at Lurie Children’s Hospital of Chicago. He has also pledged to give half of his wealth to philanthropic works.Eric’s love and dedication towards making artificial intelligence work, especially in the fields of medicine are enormous. Tempus equips physicians with these great resources for them to meet patients’ needs at a much better level. At Tempus, the genome data is sequenced in the laboratories before being analyzed; the results are then sent to the individual physician who, after consultation and research, helps validate screening of therapies to take place in animal models. Eric has been of great help to healthcare provision around the world.

Source of the article: http://shiakapos.com/eric-lefkofskys-biggest-deal-yet-hes-using-data-to-fight-cancer/